openPR Logo
Press release

US FDA Final Rule Categorizes the Safety and Effectiveness of 28 Consumer Hand Sanitizer Active Ingredients

05-10-2019 01:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: SGS

/ PR Agency: Sugarloaf Marketing
The US Food and Drug Administration (FDA) has published a final rule on the safety and effectiveness of 28 active ingredients used in consumer hand sanitizers.

These 28 active ingredients are considered Category II – not generally recognized as safe and effective or misbranded. They include:
1. Benzethonium chloride
2. Chloroxylenol
3. Chlorhexidine gluconate
4. Cloflucarban
5. Fluorosalan
6. Hexachlorophene
7. Hexylresorcinol
8. Iodine complex (ammonium ether sulfate and polyoxyethylene sorbitan monolaurate)
9. Iodine complex (phosphate ester of alkylaryloxy polyethylene glycol)
10. Methylbenzethonium chloride
11. Nonylphenoxypoly (ethyleneoxy) ethanoliodine
12. Phenol (equal to or less than 1.5 percent or greater than 1.5 percent)
13. Poloxamer iodine complex
14. Povidone-iodine 5 to 10 percent
15. Secondary amyltricresols
16. Sodium oxychlorosene
17. Tribromsalan
18. Triclocarban
19. Triclosan
20. Triple dye
21. Undecoylium chloride iodine complex
22. Polyhexamethylene biguanide
23. Benzalkonium cetyl phosphate
24. Cetylpyridinium chloride
25. Salicylic acid
26. Sodium hypochlorite
27. Tea tree oil
28. Combination of potassium vegetable oil solution, phosphate sequestering agent, and triethanolamine

The FDA believes the nonmonograph status of these ingredients means they affect less than 3% of consumer antiseptic rubs, otherwise known as hand sanitizers, currently in the marketplace.

The FDA has also deferred making a final rule on the following three substances to allow the development and submission of new safety and effectiveness data. They are:
• Ethanol
• Isopropyl alcohol
• Benzalkonium chloride

In addition, the statistical analysis used for efficacy has been updated. It now requires bacterial log reduction studies to continue as a demonstration that an active ingredient is effective. The rules also require substances to participate in a randomized three-arm study containing:
1. Test
2. Active control
3. Negative control

The statistical analysis related to the log reduction criteria for classifying consumer antiseptic rub active ingredients is also to be considered Generally Recognized as Effective (GRAE).

The FDA has also updated the following requirements for testing efficacy:
• The test product should be non-inferior to an FDA-approved antiseptic rub as active control with a 0.5 margin (log10 scale)
• Requiring the test product should be superior to the negative control by a margin of 1.5 (log10 scale)
• A minimum sample size of 100 subjects per treatment arm
• Two adequate and well-controlled clinical simulation pivotal studies for the consumer antiseptic rub indication at two separate independent laboratory facilities by independent principal investigators must be conducted

Stakeholders are now advised to make sure their products comply with the latest regulations before offering hand sanitizers onto the market in the US.

SGS Cosmetics & Personal Care Testing Services
SGS provides testing, inspection, auditing and consulting services to manufacturers, distributors and importers to ensure a high level of product quality in every area. A global network of state-of-the-art laboratories offer custom-made solutions for chemical, biophysical, microbiological, stability and biological aspects. Learn more about SGS’s Cosmetics & Personal Care Testing Services. (www.sgs.com/en/consumer-goods-retail/cosmetics-personal-care-and-household/cosmetics-and-personal-care/testing)

SGS SafeGuardS keep you up to date with the latest news and developments in the consumer goods industry. Read the full US FDA Issues Final Rule on Safety and Effectiveness of Consumer Hand Sanitizers SafeGuardS. [www.sgs.com/en/news/2019/04/safeguards-05919-us-fda-issues-final-rule-on-safety-and-effectiveness-of-consumer-hand-sanitizers]

Subscribe here, www.sgs.com/subscribesg, to receive SGS SafeGuardS direct to your inbox.

For further information contact:

Joseph Scognamiglio
Technical Manager
Tel: +1 973-461-7937
Email: crs.media@sgs.com
Website: www.sgs.com/cosmetics

SGS is the world’s leading inspection, verification, testing and certification company. SGS is recognized as the global benchmark for quality and integrity. With more than 97,000 employees, SGS operates a network of over 2,600 offices and laboratories around the world.

1, Mons Calpe
Chitcombe Road
Broad Oak
Rye
East sussex
TN31 6EU

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US FDA Final Rule Categorizes the Safety and Effectiveness of 28 Consumer Hand Sanitizer Active Ingredients here

News-ID: 1734768 • Views: 1102

More Releases from SGS

Experienced Willy Fabritius Joins SGS
With over a quarter of a century of experience in IT, information security and international standards, Willy Fabritius has joined world-leading testing, inspection and certification company SGS. Willy accepted the role of Global Head of Strategy and Business Development, Information Security Assurance this summer. He says: “I am delighted to join SGS, which has the incredible reputation of providing superb information security solutions across the world. “I will use my in-depth knowledge
SGS opens doors to new markets with publication of latest ‘Global Access Progr …
SGS, the world’s leading inspection, verification, testing and certification company, is pleased to announce publication of the latest version of its Global Access Program (GAP) for Electrical & Electronics Products white paper. With the continuous growth of worldwide trading business, and more countries and regions establishing their own type-approval systems, the GAP white paper has become an essential reference for Electrical & Electronics (E&E) manufacturers and importers looking to reach new
Ecuador Issues Revised Draft Technical Regulation on Food Contact Ceramics
Ecuador has announced a revised proposal that, if accepted, will update its technical regulation for food contact ceramics. The latest proposal, designated Ecuadorian Technical Regulation RTE UNEN 010 (2R) – ‘Ceramic Tableware Intended to Come into Contact with Food’, was circulated attached to World Trade Organization (WTO) document no. 20-4675 on July 8, 2020. It has a new structure and contains several important changes, including: • Revision to existing definitions and
SGS puts Consumer Trust at the Heart of its new Brand Awareness Campaign
SGS, the world’s leading inspection, testing and certification company, has today launched ‘Trusted. Tested.’ – a high impact, brand awareness campaign to engage consumers in the vital role of testing, inspection and certification on the everyday products they purchase. With the strapline ‘It’s only trusted because it’s tested’, the campaign showcases more than 50 everyday products that typically pass through SGS’s testing laboratories – from lipsticks and shoes to mobile phones

All 5 Releases


More Releases for FDA

FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
Peyronie’s Disease Market - Only FDA approved product
The market is dominated by a single player, Endo International plc who sells the only FDA approved Peyronie’s disease product. In May 2015, the American Urological Association presented the first ever treatment guidelines for Peyronie’s disease recommending the use of Xiaflex. Furthermore, the company is creating awareness through its “Ask About the Curve” campaign. Also, reimbursement from the U.S. insurance providers will boost the demand for this product. The product
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding